Biological therapy articles within Scientific Reports

Featured

• Article
  06 May 2024 | Open Access

  Ratio of plasma IL-13/TNF- ∝ and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E level

  • Ayobami Akenroye
  • , Tanawin Nopsopon
  •  & Tanya M. Laidlaw

• Article
  16 January 2024 | Open Access

  Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

  • Guillaume Larid
  • , Guy Baudens
  •  & Elisabeth Gervais

• Article
  12 January 2024 | Open Access

  Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database

  • Vishnu Eshwar
  •  & Ashwin Kamath

• Article
  23 September 2023 | Open Access

  Cutaneous wound healing promoted by topical administration of heat-killed Lactobacillus plantarum KB131 and possible contribution of CARD9-mediated signaling

  • Shinyo Ishi
  • , Emi Kanno
  •  & Kazuyoshi Kawakami

• Article
  29 June 2023 | Open Access

  Enhancing human resilience beyond COVID-19-related stress: public responses to multi-benefits of home gardening

  • Chen-Fa Wu
  • , Luu Van Thong Trac
  •  & Chiu-Chuan Chen

• Article
  21 January 2023 | Open Access

  Identification of platelet subpopulations in cryopreserved platelet components using multi-colour imaging flow cytometry

  • Lacey Johnson
  • , Pearl Lei
  •  & Denese C. Marks

• Article
  15 November 2022 | Open Access

  TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System

  • Hugo Jourdain
  • , Léa Hoisnard
  •  & Mahmoud Zureik

• Article
  20 October 2022 | Open Access

  Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis

  • David McConnell
  • , Marie Harte
  •  & Roisin Adams

• Article
  30 August 2022 | Open Access

  Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking

  • Karnpob Kanhasut
  • , Kannan Tharakaraman
  •  & Ram Sasisekharan

• Article
  16 July 2022 | Open Access

  A human tissue-based assay identifies a novel carrion blowfly strain for maggot debridement therapy

  • Takuma Yoshida
  • , Hiroka Aonuma
  •  & Hirotaka Kanuka

• Article
  03 May 2022 | Open Access

  Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

  • Léa Hoisnard
  • , Bénédicte Lebrun-Vignes
  •  & Emilie Sbidian

• Article
  25 November 2021 | Open Access

  Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects

  • Masanari Shiramoto
  • , Tatsuya Yoshihara
  •  & Hideya Muto

• Article
  22 July 2021 | Open Access

  Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera

  • Marten Beeg
  • , Cesare Burti
  •  & Marco Gobbi

• Article
  30 September 2020 | Open Access

  Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis

  • Maria Chiara Ditto
  • , Simone Parisi
  •  & Enrico Fusaro

• Article
  20 March 2020 | Open Access

  Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct

  • Ziya Kalem
  • , Muberra Namli Kalem
  •  & Timur Gurgan

• Article
  18 April 2018 | Open Access

  Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica

  • Debananda Gogoi
  • , Neha Arora
  •  & Ashis K. Mukherjee

• Article
  21 March 2018 | Open Access

  Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease

  • J. Scott Crowe
  • , Kevin J. Roberts
  •  & Michael R. West

• Article
  20 December 2017 | Open Access

  EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’ of α-Synuclein

  • Jee Eun Yang
  • , Kun Yil Rhoo
  •  & Seung R. Paik

• Article
  14 July 2017 | Open Access

  Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis

  • Norihiko Sakai
  • , Miki Nakamura
  •  & Takashi Wada

• Article
  12 April 2017 | Open Access

  The effect of L-PRF membranes on bone healing in rabbit tibiae bone defects: micro-CT and biomarker results

  • Fernanda Faot
  • , Sanne Deprez
  •  & Joke Duyck

• Article
  01 June 2016 | Open Access

  A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67

  • Sijia Wang
  • , Gereon Hüttmann
  •  & Ramtin Rahmanzadeh